Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
- Conditions
- NAFLD
- Interventions
- Other: No interventionBehavioral: Caloric restriction intervention
- Registration Number
- NCT05842850
- Lead Sponsor
- Steno Diabetes Center Copenhagen
- Brief Summary
The investigators will conduct a proof-of-principle deep phenotyping 4-weeks caloric restriction intervention study in low birth weight (LBW) subjects with NAFLD and normal birth weight (NBW) controls. Furthermore, the investigators will provide extended in-depth mechanistic insight into the role of impaired subcutaneous adipose tissue (SAT) expandability in ectopic fat deposition in LBW subjects in LBW individuals with and without NAFLD.
- Detailed Description
An adverse fetal environment characterized by low birth weight (LBW) plays a key role in the development of type 2 diabetes (T2D). The investigators recently demonstrated a 3-fold increase in liver fat in 26 early middle-aged LBW compared to 22 normal birth weight (NBW) men, and 20% of the LBW - but none of the normal birth weight (NBW) - men had previously unknown non-alcoholic fatty liver disease (NAFLD). The investigators hypothesize that ectopic fat deposition and NAFLD is among the earliest disease manifestations and on the critical path to the development of more severe cardiometabolic disease in LBW. The investigators furthermore hypothesize, that LBW individuals exhibit ectopic liver fat due to reduced capacity to store fat in the subcutaneous adipose tissue (SAT) depot, and that early detection and subsequent intensive caloric restriction, in middle-aged LBW individuals with overt NAFLD, may represent a targeted and highly efficient way forward to prevent more severe cardiometabolic disease manifestations in LBW subjects. To further explore the recent findings, the investigators aim to perform an extended nested case-control screening study for NAFLD in 250 early middle-aged non-obese LBW men and women, and subsequently to conduct a deep-phenotyping, proof-of-principle 4 week time-restricted eating (TRE) intervention study in 12 LBW subjects with NAFLD including measures of hepatic fat content, glucose, insulin and lipid metabolism, as well as 24h metabolic profiles using respiratory chambers. Finally, the investigators will provide extended in-depth mechanistic insight into transcriptional, epigenetic as well as functional SAT and preadipocyte perturbations underlying impaired SAT expandability in LBW individuals with and without NAFLD and NBW controls studied before and after different dietary interventions including TRE and high carbohydrate overfeeding.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 24
- LBW subjects with NAFLD (liver fat content ≥5% liver fat content verified on MRS)
- Gender- and body mass index-matched NBW controls without NAFLD
- Born at term (weeks 39-41)
- BMI<18.5 and BMI>30 kg/m2
- Family history of diabetes (siblings, parent, and grandparents)
- Disease/medication known to affect primary outcome
- Self-reported high physical activity level
- Alcohol intake above general recommendations.
- Metabolic/liver disease
- Weight gain/loss of >3 kg within the past 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description NBW controls without NAFLD No intervention Age-, gender- and body mass index-matched NBW controls without NAFLD LBW individuals with NAFLD Caloric restriction intervention LBW individuals with NAFLD
- Primary Outcome Measures
Name Time Method Liver fat content Change from baseline in liver fat content at 4 weeks Validation by Magnetic resonance spectroscopy (MRS)
- Secondary Outcome Measures
Name Time Method Liver fibrosis Baseline and after 4 weeks Liver elastography (FibroScan)
Fat turnover rate Baseline and after 4 weeks Stable isotope dilution techniques
Urea turnover rate Baseline and after 4 weeks Stable isotope dilution techniques
Beta-cell function Baseline and after 4 weeks Intravenous glucose tolerance test
Whole-body insulin sensitivity Baseline and after 4 weeks Stepwise hyperinsulinemic-euglycemic clamp
24-hour energy metabolism Baseline and after 4 weeks Indirect calorimetry in respiratory chamber
Glucose turnover rate Baseline and after 4 weeks Stable isotope dilution technique
Body composition Baseline and after 4 weeks DEXA scan